Your browser doesn't support javascript.
loading
A phase II trial of trebananib (AMG 386; IND#111071), a selective angiopoietin 1/2 neutralizing peptibody, in patients with persistent/recurrent carcinoma of the endometrium: An NRG/Gynecologic Oncology Group trial.
Moore, Kathleen N; Sill, Michael W; Tenney, Meaghan E; Darus, Christopher J; Griffin, David; Werner, Theresa L; Rose, Peter G; Behrens, Robert.
Afiliação
  • Moore KN; Stephenson Oklahoma Cancer Center, 800 NE 10th Street, Oklahoma City, OK 73104, United States. Electronic address: Kathleen-Moore@ouhsc.edu.
  • Sill MW; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263, United States. Electronic address: msill@gogstats.org.
  • Tenney ME; University of Chicago, 5841 S. Maryland Avenue, Chicago, IL 60637, United States. Electronic address: mtenney@babies.bsd.uchicago.edu.
  • Darus CJ; Maine Medical Center, 102 Campus Drive Unit 116, Scarborough, ME 04074, United States. Electronic address: darusc@mmc.org.
  • Griffin D; Upstate Carolina CCOP Oncology Research, 101 East Wood Street, Spartanburg, SC 29303, United States. Electronic address: david_griffin@bshsi.org.
  • Werner TL; Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Salt Lake City, UT 84112, United States. Electronic address: theresa.werner@hci.utah.edu.
  • Rose PG; Cleveland Clinic Foundation, 9500 Euclid Avenue, A81, Cleveland, OH 44106, United States. Electronic address: rosep@ccf.org.
  • Behrens R; Cancer Center of Iowa, Iowa Wide Oncology Research Coalition, 1221 Pleasant Street, Suite 450, Des Moines IA 50309, United States. Electronic address: rbehrens@cancercenterofiowa.com.
Gynecol Oncol ; 138(3): 513-8, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26171911

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Neoplasias do Endométrio / Inibidores da Angiogênese Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Neoplasias do Endométrio / Inibidores da Angiogênese Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article